Cellective Dx Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 8
Employees
  • Latest Deal Type
  • M&A

Cellective Dx General Information

Description

Developer of diagnostic, monitoring and molecular analytical tools for cancer. The company's diagnostic tools are based on the analysis of CTCs from patient's blood. Its technologies combine microfluids, flow dynamics, cell biology, molecular biology, biochemistry and surface chemistry to capture and analyze rare CTCs in blood.

Contact Information

Formerly Known As
CellPoint Diagnostics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Acquirer
On-Q-ity
Primary Office
  • 265 North Whisman Road
  • Mountain View, CA 94043
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellective Dx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 31-May-2009 000.00 Completed Startup
5. Early Stage VC (Series B) 13-May-2009 00.000 000.00 000.00 Completed Generating Revenue
4. Convertible Debt 19-Aug-2008 000 000.00 Completed Startup
3. Early Stage VC (Series A1) 13-Sep-2007 000.00 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 16-Sep-2006 $8.5M $8.5M 000.00 Completed Startup
1. Grant 01-Jan-2006 $142K Completed Startup
To view Cellective Dx’s complete valuation and funding history, request access »

Cellective Dx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 9,806,039 $0.001000 $0.07 $0.92 $0.92 1x $0.92 21.02%
To view Cellective Dx’s complete cap table history, request access »

Cellective Dx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellective Dx Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mohr Davidow Ventures Venture Capital Minority 000 0000 000000 0
Northgate Capital Fund of Funds Minority 000 0000 000000 0
Northport Investments PE/Buyout Minority 000 0000 000000 0
Paperboy Ventures Merchant Banking Firm Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Cellective Dx’s complete investors history, request access »